Search filters

List of works by Marek Jarema

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

scientific article published on 06 July 2018

A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern Europe

scientific article published on 8 May 2017

A few facts from the history of selected biological treatment methods in psychiatry

scientific article

Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.

scientific article published on 15 June 2011

Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?

scientific article published on 24 November 2014

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study

scientific article published on April 2014

Antipsychotics in clinical practice. Treatment of the first schizophrenic episode

scientific article published in November 2008

Are we able to evaluate suicide risk?

scientific article published on 28 February 2018

Atypical antipsychotics in the treatment of mood disorders

scientific article published on January 2007

Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics

scientific article

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

scientific article published on 15 July 2016

Biological treatment of mental disorders

scientific article published in November 2008

Body Image and Body Experience Disturbances in Schizophrenia: an Attempt to Introduce the Concept of Body Self as a Conceptual Framework.

scientific article published on 25 November 2016

CT and MRI white-matter lesions in Alzheimer's disease

Clinical determinants of mental disorders occurring during the infertility treatment

scientific article

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology

scientific article published on August 2015

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics

scientific article

Current concepts of pharmacological treatment in schizophrenia

scientific article published on 01 November 2002

Cytokines, sleep and wakefulness regulation, and general health: a commentary to the review "The influence of cytokines on wakefulness regulation"

scientific article published on June 1, 2012

Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agents.

scientific article published on 2 August 2014

Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients.

scientific article published in May 2017

Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

scientific article

Elective cesarean section on psychiatric indications - the phenomenon analysis, report of two cases and psychiatric clinical recommendations

scientific article

Electroencephalographic theta activity and cognition in schizophrenia: preliminary results

scientific article published on 24 October 2014

Eszopiclone in the treatment of insomnia

Experience of stigma and discrimination reported by people experiencing the first episode of schizophrenia and those with a first episode of depression: The FEDORA project

scientific article published on 8 October 2014

Fighting stigma of mental illness in midsize European countries

scientific article published on April 2012

From the history of Polish psychiatry: paragnomen

Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype

scientific article published on 27 November 2014

Guidelines for the use of second-generation long-acting antipsychotics

scientific article published on 01 March 2015

Herbal drug treatment.

scientific article

Hypersomnia and cognitive impairment in a patient with bipolar disorder - a case report.

scientific article published on 18 June 2017

Letter to Editor. In search of definition of the term "psychotic process" - thoughts and doubts

scientific article published on 30 April 2017

Letter to the editors

scientific article published on 01 January 2007

Long-term assessment of the efficacy and tolerability of risperidone in early schizophrenia: An international multicenter study

scientific article published in January 2004

Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmac

MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia

scientific article published on March 1, 2012

Myth and reality of pragmatic trials.

scientific article published in March 2010

Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia-A Systematic Review

scientific article published on 16 August 2019

Oxytocin model of formation of psychotic symptoms and its implication for research concerning oxytocinergic pathway in schizophrenia

Oxytocin model of formation of psychotic symptoms and its implications for research on oxytocinergic pathway in schizophrenia

scientific article published in January 2014

Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia

scientific article

Practical aspects of the use of ziprasidone in schizophrenia

scientific article published on November 1, 2010

Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial

scientific article published on July 1, 2003

Schizophrenia causes significant burden to patients' and caregivers' lives

scientific article published on June 2016

Schizophrenia plus – comorbidity of schizophrenia and personality disorders. Clinician’s reflections

Stigma in Midsize European Countries

Stigmatization of psychiatrists and general practitioners: results of an international survey.

scientific article published on 5 September 2014

Strategies of long-term treatment of psychotic disorders.

scientific article published in February 2007

Subjective and objective evaluation of olanzapine treatment in schizophrenia

scientific article

The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties

scientific article

The Predictive Value of Psychopathological Subclassifications for the Neuroleptic Treatment Outcome in Schizophrenia ⬇️

scientific article published on 01 January 1991

The controversy around the diagnosis of selective mutism - a critical analysis of three cases in the light of modern research and diagnostic criteria

scientific article published on 30 April 2018

The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial

scientific article published in March 2015

Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression

scientific article published on 01 July 2011

Treatment of depression in first episode of schizophrenia: results from EUFEST.

scientific article published on 23 May 2012

Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries

scientific article

Virtual reality – a valuable tool to advance treatment of mental disorders

Zespół psychoorganiczny — historia a współczesność

[Acute psychiatric diseases]

scientific article published on 01 November 2007

[Androgens - a common biological marker of sleep disorders and selected sexual dysfunctions?]

scientific article published on 01 July 2014

[Antipsychotics in clinical practice. The refractory schizophrenic patients treatment].

scientific article published in November 2008

[Between health and schizophrenia].

scientific article

[Cognitive dysfunctions in depression - underestimated symptom or new dimension?]

scientific article published on 01 November 2014

[Cognitive rehabilitation for people living with schizophrenia - the newest interventions]

scientific article published on 01 November 2014

[Pharmacological standards in schizophrenia treatment]

scientific article published on 01 November 2006

[Second generation antipsychotics: similarities and differences]

scientific article published on 01 January 2003

[Second generation of neuroleptics--expectations and the reality]

scientific article published on 01 November 2002

[Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment]

scientific article published on 01 March 2009

[The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report]

scientific article published on 01 November 2014

[The change of quality of life and clinical picture in schizophrenia]

scientific article published on 01 May 2002

Paulina is supported by:

About Paulina

Help